- Home
- PATH vs ADMA Comparison
PATH vs ADMA Comparison
Compare PATH & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PATH
- ADMA
- Stock Information
- Founded
- PATH 2005
- ADMA 2004
- Country
- PATH United States
- ADMA United States
- Employees
- PATH N/A
- ADMA N/A
- Industry
- PATH Computer Software: Prepackaged Software
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PATH Technology
- ADMA Health Care
- Exchange
- PATH Nasdaq
- ADMA Nasdaq
- Market Cap
- PATH 6.0B
- ADMA 5.8B
- IPO Year
- PATH 2021
- ADMA N/A
- Fundamental
- Price
- PATH $12.49
- ADMA $19.98
- Analyst Decision
- PATH Hold
- ADMA Strong Buy
- Analyst Count
- PATH 20
- ADMA 4
- Target Price
- PATH $12.91
- ADMA $24.25
- AVG Volume (30 Days)
- PATH 12.4M
- ADMA 4.5M
- Earning Date
- PATH 05-29-2025
- ADMA 05-07-2025
- Dividend Yield
- PATH N/A
- ADMA N/A
- EPS Growth
- PATH N/A
- ADMA N/A
- EPS
- PATH N/A
- ADMA 0.84
- Revenue
- PATH $1,429,664,000.00
- ADMA $459,381,000.00
- Revenue This Year
- PATH $8.91
- ADMA $18.45
- Revenue Next Year
- PATH $8.99
- ADMA $26.96
- P/E Ratio
- PATH N/A
- ADMA $23.92
- Revenue Growth
- PATH 9.30
- ADMA 62.23
- 52 Week Low
- PATH $9.38
- ADMA $6.84
- 52 Week High
- PATH $20.95
- ADMA $25.67
- Technical
- Relative Strength Index (RSI)
- PATH 66.90
- ADMA 43.06
- Support Level
- PATH $11.63
- ADMA $18.75
- Resistance Level
- PATH $12.12
- ADMA $23.98
- Average True Range (ATR)
- PATH 0.35
- ADMA 1.38
- MACD
- PATH 0.15
- ADMA -0.34
- Stochastic Oscillator
- PATH 95.53
- ADMA 17.77
About PATH UiPath Inc.
UiPath Inc offers an end-to-end cross-application enterprise automation platform principally with computer vision technology and user interface automations in its initial RPA offering, which remains the foundation of the platform. The platform leverages a range of automation technologies including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries including claims processing, employee onboarding, invoice to cash, loan applications, and customer service.
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.